Coronary Restenosis
Research News and Information

Monday, November 23, 2009

Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.

30 Oct 2009 Restenosis is a major complication of percutaneous transluminal coronary angioplasty (PTCA) and is characterized by increased superoxide formation and accumulation of smooth muscle cells (SMCs). The mechanisms through which peroxisome ... Read more...

Drug-eluting stents: a study of international practice.

29 Sep 2009 OBJECTIVE: We aimed to analyze trends in drug-eluting stents (DES) use in four international health care and regulatory settings. BACKGROUND: Accounts suggest a differential approach to DES internationally and recent reductions in use following ... Read more...

Design and rationale of the TRI-stent adjudication study (TRIAS) program.

29 Sep 2009 BACKGROUND: In the treatment of coronary artery disease, a "pro-healing" approach for prevention of in-stent restenosis and late stent thrombosis is intuitively favored over the use of cytotoxic or cytostatic drugs released from a drug-eluting stent ... Read more...

Latest indexed articles for 'Coronary Restenosis'

These are the very latest articles for this heading:

• Stuck in the wrong place. 30 Oct 2009
• Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. 30 Oct 2009
• Drug-eluting stents: a study of international practice. 29 Sep 2009
• Design and rationale of the TRI-stent adjudication study (TRIAS) program. 29 Sep 2009
• Genetic susceptibility to restenosis: role of bone marrow cells and inflammatory response. 29 Sep 2009
• Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. 26 Sep 2009
• Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). 20 Sep 2009
• New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. 6 Sep 2009
• Importance of creativity: new applications of the Proxis catheter. 30 Aug 2009
• Novel uses of the Proxis embolic protection catheter. 30 Aug 2009
• Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation. 30 Aug 2009
• 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. 30 Aug 2009
• Hybrid coronary artery revascularization: an evidence-based analysis. 30 Aug 2009
• Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. 26 Aug 2009
• [Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics] 24 Aug 2009
• Are we sure we have taken the best from clopidogrel? 24 Aug 2009
• The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem? 20 Aug 2009
• Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. 19 Aug 2009
• p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity. 8 Aug 2009
• Stent underexpansion in early drug-eluting stent thrombosis. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Coronary Restenosis'

Definition: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Descriptor UI: D023903

Alternative terms: Coronary Restenosis; Coronary Restenoses; Restenoses, Coronary; Restenosis, Coronary;

Allowable Qualifiers: drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology; blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy;

Tree Number: C14.280.647.250.285.200; C14.907.585.250.285.200;

History Note: 2002